BRAINSTORM CELL

BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the treatment of highly debilitating neurodegenerative diseases... BrainStorm is dedicated to defeating neurodegenerative diseases using an innovative, best-in-class, autologous cellular therapeutic technology platform, NurOwn®... BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Alzheimer's Disease (AD).

Also known as: BrainStorm, BrainStorm Cell Limited, Brainstorm Cell Therapeutics Ltd., BrainStorm Cell Therapeutics, Inc.

Primary location: New York United States